Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Egis Pharmaceuticals PLC

02 12care4

03 4Accord healthcare

04 14Amdipharm Mercury Company Limited

05 4Biological E

06 8Centocor

07 12Exeltis

08 29Janssen-Cilag

09 15Johnson & Johnson Innovative Medicine

10 5Laboratorios Liconsa

11 6Luye Pharma

12 12Neuraxpharm

13 1Pharmascience Inc.

14 23Pharmathen SA

15 1Ratiopharm Espana Sa

16 9STADA Arzneimittel

17 19Teva Pharmaceutical Industries

18 5Tolmar

19 6Viatris

20 4Zentiva

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothExpand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Regulatory Info : Prescription

Registration Country : Denmark

Paliperidone Palmitate

Brand Name : Egoropal

Dosage Form : Suspension In Pre-Filled Syringe

Dosage Strength : 100mg; 150mg

Packaging :

Approval Date : 06-05-2022

Application Number : 28106441120

Regulatory Info : Prescription

Registration Country : Denmark

Egis Pharmaceuticals

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothExpand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Regulatory Info : Prescription

Registration Country : Denmark

Paliperidone Palmitate

Brand Name : Egoropal

Dosage Form : Suspension In Pre-Filled Syringe

Dosage Strength : 100mg

Packaging :

Approval Date : 06-05-2022

Application Number : 28106440920

Regulatory Info : Prescription

Registration Country : Denmark

Egis Pharmaceuticals

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothExpand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Regulatory Info : Prescription

Registration Country : Denmark

Paliperidone Palmitate

Brand Name : Egoropal

Dosage Form : Suspension In Pre-Filled Syringe

Dosage Strength : 150mg

Packaging :

Approval Date : 06-05-2022

Application Number : 28106441020

Regulatory Info : Prescription

Registration Country : Denmark

Egis Pharmaceuticals

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothExpand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Regulatory Info : Prescription

Registration Country : Denmark

Paliperidone Palmitate

Brand Name : Egoropal

Dosage Form : Suspension In Pre-Filled Syringe

Dosage Strength : 25mg

Packaging :

Approval Date : 06-05-2022

Application Number : 28106440620

Regulatory Info : Prescription

Registration Country : Denmark

Egis Pharmaceuticals

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothExpand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Regulatory Info : Prescription

Registration Country : Denmark

Paliperidone Palmitate

Brand Name : Egoropal

Dosage Form : Suspension In Pre-Filled Syringe

Dosage Strength : 50mg

Packaging :

Approval Date : 06-05-2022

Application Number : 28106440720

Regulatory Info : Prescription

Registration Country : Denmark

Egis Pharmaceuticals

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothExpand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Regulatory Info : Prescription

Registration Country : Denmark

Paliperidone Palmitate

Brand Name : Egoropal

Dosage Form : Suspension In Pre-Filled Syringe

Dosage Strength : 75mg

Packaging :

Approval Date : 06-05-2022

Application Number : 28106440820

Regulatory Info : Prescription

Registration Country : Denmark

Egis Pharmaceuticals

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA SUSTENNA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 39MG/0.25ML (39MG/0.25ML)

Packaging :

Approval Date : 2009-07-31

Application Number : 22264

Regulatory Info : RX

Registration Country : USA

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA SUSTENNA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 78MG/0.5ML (78MG/0.5ML)

Packaging :

Approval Date : 2009-07-31

Application Number : 22264

Regulatory Info : RX

Registration Country : USA

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA SUSTENNA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 117MG/0.75ML (117MG/0.75ML)

Packaging :

Approval Date : 2009-07-31

Application Number : 22264

Regulatory Info : RX

Registration Country : USA

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA SUSTENNA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 156MG/ML (156MG/ML)

Packaging :

Approval Date : 2009-07-31

Application Number : 22264

Regulatory Info : RX

Registration Country : USA

blank

11

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA SUSTENNA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 234MG/1.5ML (156MG/ML)

Packaging :

Approval Date : 2009-07-31

Application Number : 22264

Regulatory Info : RX

Registration Country : USA

blank

12

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA TRINZA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 273MG/0.875ML (273MG/0.875ML)

Packaging :

Approval Date : 2015-05-18

Application Number : 207946

Regulatory Info : RX

Registration Country : USA

blank

13

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA TRINZA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 410MG/1.315ML (311.79MG/ML)

Packaging :

Approval Date : 2015-05-18

Application Number : 207946

Regulatory Info : RX

Registration Country : USA

blank

14

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA TRINZA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 546MG/1.75ML (312MG/ML)

Packaging :

Approval Date : 2015-05-18

Application Number : 207946

Regulatory Info : RX

Registration Country : USA

blank

15

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA TRINZA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 819MG/2.625ML (312MG/ML)

Packaging :

Approval Date : 2015-05-18

Application Number : 207946

Regulatory Info : RX

Registration Country : USA

blank

16

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA HAFYERA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 1.092GM/3.5ML (312MG/ML)

Packaging :

Approval Date : 2021-08-30

Application Number : 207946

Regulatory Info : RX

Registration Country : USA

blank

17

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : INVEGA HAFYERA

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 1.560GM/5ML (312MG/ML)

Packaging :

Approval Date : 2021-08-30

Application Number : 207946

Regulatory Info : RX

Registration Country : USA

blank

18

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : PALIPERIDONE PALMITATE

Dosage Form : SUSPENSION;EXTENDED RELEASE

Dosage Strength :

Packaging :

Approval Date :

Application Number : 210397

Regulatory Info :

Registration Country : USA

blank

19

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : PALIPERIDONE PALMITATE

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 39MG/0.25ML

Packaging :

Approval Date :

Application Number : 211995

Regulatory Info :

Registration Country : USA

blank

20

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

PALIPERIDONE PALMITATE

Brand Name : PALIPERIDONE PALMITATE

Dosage Form : SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

Dosage Strength : 78MG/0.5ML

Packaging :

Approval Date :

Application Number : 211995

Regulatory Info :

Registration Country : USA

blank